Firstly, I sincerely hope that you are keeping safe and well in these challenging times. The coronavirus has presented significant challenges to all people, in all walks of life, and I am conscious that the road ahead will likely present further hurdles which we must all work together to overcome.
Nicola MusgroveAn update from the Managing Director
I hope this post finds you in good health and largely unaffected by recent events.
Here at Oxinet, we have been closely monitoring the COVID-19 (Corona Virus) pandemic and government guidance as issued. The most important priority for us is the health and safety of our customers, suppliers, and our dedicated staff.
Nicola MusgroveA statement on COVID-19 from the Managing Director, Graham Steinsberg
February saw the release of the much-anticipated sequel to Sir Robert Francis’ initial Mid-Staffs inquiry findings, this time focusing specifically on the lack of support for NHS staff wishing to “blow the whistle” on perceived poor care. Having been grimly primed somewhat by the first report, the findings of the second review are hardly unexpected – but the lack of shock does little to mitigate the seriousness of Francis’ conclusions.
Nicola MusgroveFrancis report on whistleblowing: a response from Oxinet
The headlines were alive last year with the sound of disapproval at the news that the UK has been ‘panic buying’ nurses from abroad. It would seem that the Government’s continued failure to invest in nurse training places in the UK has finally caught up with us, leaving us with just shy of 6,000 overseas-trained nurses working in our healthcare system.
Claire Bunyan“Astonishing”: lack of investment in UK nurse education comes back to bite Britain’s healthcare system.